Status:
NOT_YET_RECRUITING
Gastric Cancer Complicated With Bleeding
Lead Sponsor:
Peking University Third Hospital
Conditions:
Gastric Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To investigate the impact of bleeding on the survival and treatment-related adverse events (TRAEs) of gastric cancer patients.
Detailed Description
We will retrospectively enroll patients diagnosed with advanced or metastatic gastric cancer at the Department of Medical Oncology and Radiation Sickness of Peking University Third Hospital. The retro...
Eligibility Criteria
Inclusion
- Patients older than 18 years;
- A histologically confirmed diagnosis of advanced or metastatic gastric cancer;
- The initial anticancer treatment was systematic therapy, including chemotherapy, targeted therapy or immune checkpoint inhibitor (ICI);
- No history of gastrectomy before systematic therapy.
Exclusion
- Incompletable clinical data;
- Siewert I type esophagus cancer.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06522542
Start Date
August 1 2024
End Date
July 31 2026
Last Update
July 26 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.